Pyruvate (13C)

DRUG2 trials

Sponsors

Rahul Aggarwal

Conditions

Prostate Cancer

Phase 1

Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer

TerminatedNCT02911467

Rahul AggarwalProstate Cancer

Start: 2016-11-08End: 2020-07-20Updated: 2020-07-24

Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies

TerminatedNCT02913131

Rahul AggarwalProstate Cancer

Start: 2016-10-20End: 2021-04-05Updated: 2022-04-22

Related Papers

Hyperpolarized C-13 pyuvate metabolic MR imaging of solid tumor liver metastases as a biomarker of PI3K/mTOR pathway activity.

Journal of Clinical Oncology2018-05-20